A triantennary GalNAc ligand known as GalNAc-L96, which efficiently binds to ASGPR, supports the targeted synthesis of GalNAc-siRNA, thereby boosting hepatocyte targeting. L2 enhances the efficiency of GalNAc-L96 synthesis, particularly in creating targeted therapeutic agents.
Molecular Weight
641.7
Molecular Formula
41H39NO6
Form
Solid
Purity
≥98%, determined by HPLC.
Impurities
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.
Identity
Conforms to structure, determined by 1H NMR.
Test Method
NMR; HPLC
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.